This guideline was written as part of information on Arsenic contamination of traditional Burmese medicines
Lead is a heavy metal. Routes of exposure to lead include contaminated air, water, soil and food.4 Hand-to-mouth activities in young children increase their risk of lead exposure. Well described sources include lead-based paint from imported toys and in older houses.6 Toxicity has also been linked to lead-contaminated traditonal remedies2, imported candies/condiments, and fashion accessories.6
Elevated blood lead concentrations have been reported in up to 7 - 13% of African5, 6 South Asian7, 8 and Burmese2, 9 refugee children, especially in those aged <6 years; although rarely to a concentration requiring chelation therapy. Blood lead screening has been recommended for all refugee children (aged 6 months - 16 years) arriving in the United States from 2011.10 Blood lead screening is not part of routine post-arrival tests in Australian refugee health guidelines, but should be considered in any child with developmental delay, pica, or where there is a history suggesting exposure, including through traditional medicines.
Clinical features of lead toxicity
Clinical features vary depending on level of exposure and age of the child; they may be non-specific.
Low level
exposure |
Moderate
exposure |
High level
exposure |
Decreased learning and memory,
lowered IQ, cognitive dysfunction Behavioural disturbance (more
marked in children) - irritability, restlessness,
sleeplessness Myalgia/paraesthesias Fatigue, lethargy Abdominal
discomfort
|
Arthralgia Vomiting, weight loss,
constipation, abdominal pain Headache Poor
concentration Muscle fatigue,
tremor
|
Lead line (blue discoloration) on
gum margins Anaemia Paralysis Encephalopathy, seizures, coma,
death
|
Investigations
Blood
lead concentrations |
Associated
outcomes |
<10 mcg/dL (normal) >10 mcg/dL >25 mcg/dL >45 mcg/dL >70 mcg/dL >100 mcg/dL
|
Normal Impaired cognitive development
(children) Anaemia GIT symptoms - consider
chelation CNS symptoms - consider
chelation Life threatening (encephalopathy,
seizures, coma) - chelation
|
Treatment
- Prevention of further lead exposure
- Blood lead concentration 10-45 mcg/dL, patient well
- Supportive therapy (treat any associated iron deficiency)
- Recheck blood lead concentration at 1 and 3 months to ensure it is decreasing
- If concentration not decreasing, consider ongoing exposure and look for source
- Blood lead concentration >45 mcg/dL, and/or patient acutely unwell with signs of lead toxicity
- Supportive therapy
- Consider chelation therapy (to bind lead and facilitate excretion)
- Notify cases of lead toxicity: online written notification within 5 days by laboratory.
Further information
References
Immigrant health resources. Authors: Dr Anthea Rhodes and Dr Georgie Paxton. Initial April 2012. Last review April 2020. Contact: georgia.paxton@rch.org.au